In the most comprehensive independent evaluation of the human beta cell line EndoC-βH1 conducted to date, a publication co-authored by lead pharmacologists and drug development experts at Novo Nordisk revealed EndoC-βH1 to be a very valuable and highly relevant tool for studying Diabetes. » Read more